Recombinant Human Transforming Growth Factor β-1 and Its Effects on Osseointegration

Journal of Craniofacial Surgery

Volumn 14, Issue 3, 2003, Pages 268-277

  Clokie, Cameron M L ^a   Bell, Richard C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone healing; Bone substitutes; Calcium sulphate; Cranial vault defects; Demineralized bone matrix

Indexed keywords

RECOMBINANT PROTEIN; TGFB1 PROTEIN, HUMAN; TITANIUM; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; AUDIOVISUAL EQUIPMENT; BONE REGENERATION; DENTAL CARE; DENTAL SURGERY; DRUG EFFECT; HISTOLOGY; HUMAN; MALE; MANDIBLE; MECHANICAL STRESS; METHODOLOGY; MINIPIG; SWINE; TOOTH IMPLANTATION; WOUND HEALING;

ANIMALS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; DENTAL STRESS ANALYSIS; HUMANS; MALE; MANDIBLE; MODELS, ANATOMIC; OSSEOINTEGRATION; RECOMBINANT PROTEINS; STRESS, MECHANICAL; SWINE; SWINE, MINIATURE; TITANIUM; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 0141836943     PISSN: 10492275     EISSN: 15363732     Source Type: Journal    
DOI: 10.1097/00001665-200305000-00003     Document Type: Article

References (27)

1. Branemark P-I, Zarb GA, Albrektsson T. Tissue Integrated Prostheses: Osseointegration in Clinical Dentistry. London: Quintessence, 1985:11-63
2. Clokie CML. The Titanium Bone Interface: A Clinical and Morphological Analysis of Osseointegration [thesis]. McGill University, Montreal, Canada, 1992
3. Van Steenberghe D. A retrospective multicenter evaluation of the survival rate of osseointegrated fixtures supporting fixed partial prostheses in the treatment of partial edentulism. J Prothest Dent 1989; 61:217
4. Bobyn JD, Pilliar RM, Cameron HU, et al. The optimum pore size for the fixation of porous surfaced metal implants by the ingrowth of bone. Clinic Orthop 1980; 150:263
5. Soballe K, Hansen ES, Brockstedt-Rasmussen H, et al. Hydroxylapatite coating enhances fixation of porous implants. Acta Orthop Scand 1990; 61:299
6. Klein CPAT, Patka P, van der Lubbe HB, et al. Plasma-sprayed coating of tetracalcium phosphate, hydroxylapatite and alpha-TCP on titanium alloy: an interface study. J Biomed Mater Res 1991; 25:53
7. Bell RC, Rahal MD, McCarthy GF, et al. Glass ionomer material and the healing of titanium implants [abstract]. Presented at the AAOMS/CAOMS meeting, Toronto, Ontario, Canada, September 19, 1995
8. Yan J, Xiang W, Baolin L, et al. Early histologic response to titanium implants complexed with bovine bone morphogenetic protein. J Prosthet Dent 1994; 71:289
9. Rutherford RB, Sampath KS, Rueger DC, et al. Use of bovine osteogenic protein to promote rapid osseointegration of endosseous dental implants. Int J Oral Maxillofac Implants 1992; 7:297
10. Massague J. The transforming growth factor-β family. Ann Rev Cell Biol 1990; 6:597
11. Assonian RK, Sporn MB. Type-beta transforming growth factor in human platelets: release during platelet degranulation and action of vascular smooth muscle cells. J Cell Biol 1986; 102:1712
12. Cheifetz S, Weatherbee M, Tsang MLS, et al. Transforming growth factor-β gene family members and bone. Endocr Rev 1994; 15:27
13. Ignotz RA, Massague J. Cell adhesion receptors as targets for transforming growth factor-β action. Cell 1987; 51:189
14. Kerr LD, Olashaw NE, Matrisioan LM. Transforming growth factor-β1 and cAMP inhibit transcription of epidermal growth factor and oncogene-induced transin RNA. J Biol Chem 1988; 263:6999
15. Pientenpol JA, Holt JT, Stein RW, et al. Transforming growth factor-β1 suppression of c-myc transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 1990; 87:3578
16. Morrone G, Cortese R, Sorrentino V. Post-transcriptional control of negative acute phase genes by transforming growth factor-beta. EMBO J 1989; 8:3767
17. Beck LS, Chen TL, Mikalauski P, et al. Recombinant human transforming growth factor-β1 (rhTGF-β1) enhances healing and strength in granulating skin wounds. Growth Factors 1991; 3:267
18. Beck LS, Deguqman L, Lee WP, et al. TGF-β1 induces bone closure of skull defects. J Bone Miner Res 1991; 6:1257
19. Beck LS, Amento E, Xu Y, et al. TGF-β1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-β1. J Bone Miner Res 1993; 8:753
20. Taniguchi Y, Tanaka T, Gotoh K, et al. Morphological study of recombinant human transforming growth factor-β1-induced cellular heterogeneity in the periosteum of rat parietal bones. Calcif Tissue Int 1993; 53:122
21. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990; 87:2220
22. Lind M, Schumacker B, Soballe K, et al. Transforming growth factor-β enhances fracture healing in rabbit tibiae. Acta Orthop Scand 1993; 64:553
23. Smith RA. The effect on TGF-β1 on osseointegration. CDA J 1995; 13:49
24. Clokie CML, Moghadam HG, Jackson MT, et al. Closure of critical sized cranial vault defects with allogeneic and alloplastic bone substitutes. J Craniofac Surg 2002; 13:111-121
25. Sennerby L, Thomsen P, Ericson L. A morphometric and biometric comparison of titanium implants inserted in rabbit cortical and cancellous bone. Int J Oral Maxillofac Implants 1992; 7:62
26. Lind M, Overgaard S, Soballe K, et al. Transforming growth factor-β1 enhances bone healing to unloaded tricalcium phosphate coated implants: an experimental study in dogs. J Orthop Res 1996; 14:343
27. Sumner DR, Turner TM, Perchio AF, et al. Enhancement of bone ingrowth by transforming growth factor-β. J Bone Joint Surg Am 1995; 77:1135